z-logo
open-access-imgOpen Access
Recombinant human growth hormone treatment in short children with renal disease: Our first experience
Author(s) -
Brankica Spasojević-Dimitrijeva,
Mirjana Kostić,
Amira Peco-Antić,
D Kruscić,
Dragoš Cvetković,
Gordana Miloševski-Lomić,
Dušan Paripović
Publication year - 2010
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh1004197s
Subject(s) - medicine , nephrology , kidney disease , human growth hormone , pediatrics , growth hormone treatment , endocrinology , hormone , growth hormone
Growth retardation is a hallmark of chronic illnesses such as chronic kidney disease in children, and it is associated with increased morbidity and mortality. The growth hormone (GH) resistance observed in uraemia can be overcome by supraphysiological doses of exogenous GH.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here